Invenomic Fund LP is a hedge fund based in Boston, Massachusetts. According to its most recent Form D, filed Jan 8, 2026, the fund has sold $45,955,947 of interests to 29 investors since its first sale in Aug 2017. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Invenomic Capital Management LP; Invenomic Private Fund GP LLC; Ali Motamed.
- Total raised
- $45,955,947Cumulative sales reported on Form D
- Investors
- 29
- First sale
- Aug 15, 2017
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Invenomic Capital Management LP; Invenomic Private Fund GP LLC; Ali Motamed
- Latest Form D
- Jan 8, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and HedgeMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures
Size compared with every hedge fund
Raised more than 35% of the 472 hedge funds based in Massachusetts, and more than 44% of all 10,157 that report sales.
Other funds with the same team
More hedge funds in Boston
- DeltaTerra Partners LP - Series DT-2$20.0M
- Mercer FFTC US Fixed Income Investment Portfolio LLC$569M
- Mercer FFTC US Equity Investment Portfolio LLC$905M
- Mercer FFTC Non-US Equity Investment Portfolio LLC$457M
- Mercer FFTC Emerging Markets Equity Investment Portfolio LLC$203M
- Liminality Partners RV LP$169M